| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M110246200 |
| P8608 | Fatcat ID | release_lbdl5z634zbwrjeh6sqdltpu44 |
| P698 | PubMed publication ID | 11790780 |
| P2093 | author name string | Qing Shi | |
| Shan Lin | |||
| David J. Thomas | |||
| Miroslav Styblo | |||
| F. Brent Nix | |||
| Josef B. Simeonsson | |||
| Karen M. Herbin-Davis | |||
| Larry L. Hall | |||
| Melinda A. Beck | |||
| P2860 | cites work | Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily | Q24291575 |
| Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine | Q24811006 | ||
| Enzymatic methylation of arsenic compounds. VII. Monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes | Q28368167 | ||
| Enzymatic reduction of arsenic compounds in mammalian systems: the rate-limiting enzyme of rabbit liver arsenic biotransformation is MMA(V) reductase | Q28377855 | ||
| Biosynthesis of dimethyl selenide from sodium selenite in rat liver and kidney cell-free systems | Q28627275 | ||
| Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity | Q33864843 | ||
| Enzymatic reduction of arsenic compounds in mammalian systems: reduction of arsenate to arsenite by human liver arsenate reductase | Q33887956 | ||
| Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes | Q33891890 | ||
| Speciation of key arsenic metabolic intermediates in human urine. | Q33925487 | ||
| Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes | Q33938954 | ||
| Methylated trivalent arsenic species are genotoxic | Q33942554 | ||
| In vitro effect of arsenical compounds on glutathione-related enzymes | Q33947670 | ||
| Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. | Q33951760 | ||
| Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver | Q34062420 | ||
| Enzymatic methylation of arsenic compounds. III. The marmoset and tamarin, but not the rhesus, monkeys are deficient in methyltransferases that methylate inorganic arsenic | Q34063257 | ||
| The cellular metabolism and systemic toxicity of arsenic | Q34401625 | ||
| Cloning and base sequence analysis of a cDNA encoding mouse lung thioether S-methyltransferase | Q36712049 | ||
| Changes in the chemical speciation of arsenic following ingestion by man | Q39144362 | ||
| Airborne arsenic exposure and excretion of methylated arsenic compounds | Q39144734 | ||
| Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic | Q40751318 | ||
| Determination of trivalent methylated arsenicals in biological matrices. | Q40788453 | ||
| Immortalisation of human urothelial cells | Q41384794 | ||
| Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity | Q41455778 | ||
| Probing the S-adenosylmethionine-binding site of rat guanidinoacetate methyltransferase. Effect of site-directed mutagenesis of residues that are conserved across mammalian non-nucleic acid methyltransferases | Q42160100 | ||
| Purification, characterization, and cloning of an S-adenosylmethionine-dependent 3-amino-3-carboxypropyltransferase in nocardicin biosynthesis | Q42538501 | ||
| Widespread occurrence of three sequence motifs in diverse S-adenosylmethionine-dependent methyltransferases suggests a common structure for these enzymes | Q42605575 | ||
| Isolation and characterization of Escherichia coli mutants affected in aerobic respiration: the cloning and nucleotide sequence of ubiG. Identification of an S-adenosylmethionine-binding motif in protein, RNA, and small-molecule methyltransferases | Q42606729 | ||
| Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. | Q43576159 | ||
| Reactions of arsenic(III) and arsenic(V) species with glutathione | Q46619791 | ||
| Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells | Q56114256 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 10795–10803 | |
| P577 | publication date | 2002-03-29 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol | |
| P478 | volume | 277 |
| Q36029266 | A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire |
| Q29417040 | A comprehensive family-based replication study of schizophrenia genes |
| Q52682982 | A cross-sectional study of general cognitive abilities among Uruguayan school children with low-level arsenic exposure, potential effect modification by methylation capacity and dietary folate. |
| Q48027899 | A human-specific AS3MT isoform and BORCS7 are molecular risk factors in the 10q24.32 schizophrenia-associated locus. |
| Q38235363 | A review on completing arsenic biogeochemical cycle: microbial volatilization of arsines in environment |
| Q34995682 | A transgenic Drosophila model for arsenic methylation suggests a metabolic rationale for differential dose-dependent toxicity endpoints |
| Q33584549 | AS3MT-mediated tolerance to arsenic evolved by multiple independent horizontal gene transfers from bacteria to eukaryotes |
| Q47621366 | Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate |
| Q36174255 | Altered arsenic disposition in experimental nonalcoholic fatty liver disease |
| Q42741080 | Analysis of arsenic metabolites in HepG2 and AS3MT-transfected cells |
| Q37146092 | Analysis of maternal polymorphisms in arsenic (+3 oxidation state)-methyltransferase AS3MT and fetal sex in relation to arsenic metabolism and infant birth outcomes: Implications for risk analysis |
| Q37486703 | Anticancer activity of small-molecule and nanoparticulate arsenic(III) complexes. |
| Q33988886 | Arsenic (+ 3 oxidation state) methyltransferase and the methylation of arsenicals in the invertebrate chordate Ciona intestinalis |
| Q36691809 | Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals. |
| Q37086650 | Arsenic biomethylation by photosynthetic organisms |
| Q28392983 | Arsenic biotransformation as a cancer promoting factor by inducing DNA damage and disruption of repair mechanisms |
| Q34478909 | Arsenic detoxification and evolution of trimethylarsine gas by a microbial arsenite S-adenosylmethionine methyltransferase |
| Q28394700 | Arsenic exposure and the induction of human cancers |
| Q28392204 | Arsenic exposure and toxicology: a historical perspective |
| Q36408243 | Arsenic exposure through drinking water is associated with longer telomeres in peripheral blood |
| Q37987437 | Arsenic metabolism and thioarsenicals. |
| Q43366392 | Arsenic methylation by a novel ArsM As(III) S-adenosylmethionine methyltransferase that requires only two conserved cysteine residues. |
| Q40816248 | Arsenic resistance in Halobacterium sp. strain NRC-1 examined by using an improved gene knockout system. |
| Q30918181 | Arsenic transport by zebrafish aquaglyceroporins. |
| Q46715874 | Arsenic(+3) and DNA methyltransferases, and arsenic speciation in tadpole and frog life stages of western clawed frogs (Silurana tropicalis) exposed to arsenate |
| Q28384235 | Arsenicals in maternal and fetal mouse tissues after gestational exposure to arsenite |
| Q48301680 | Arsenite-induced formation of hydroxyl radical in the striatum of awake rats |
| Q34023701 | Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions |
| Q37146959 | Biotransformation of arsenic by a Yellowstone thermoacidophilic eukaryotic alga |
| Q33755252 | Chronic Kidney Disease and Exposure to Nephrotoxic Metals |
| Q36849184 | Comparative oxidation state specific analysis of arsenic species by high-performance liquid chromatography-inductively coupled plasma-mass spectrometry and hydride generation-cryotrapping-atomic absorption spectrometry |
| Q46426987 | Conserved cysteine residues determine substrate specificity in a novel As(III) S-adenosylmethionine methyltransferase from Aspergillus fumigatus |
| Q34599799 | Creatinine, arsenic metabolism, and renal function in an arsenic-exposed population in Bangladesh |
| Q43184092 | Delivery and visualization of proteins conjugated to quantum dots in cardiac myocytes |
| Q28388011 | Determinants and Consequences of Arsenic Metabolism Efficiency among 4,794 Individuals: Demographics, Lifestyle, Genetics, and Toxicity |
| Q81455718 | Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and di-methylated metabolites |
| Q24536026 | Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children |
| Q44170423 | Differential effects of arsenic on folate binding protein 2 (Folbp2) null and wild type fibroblasts |
| Q34137513 | Direct analysis and stability of methylated trivalent arsenic metabolites in cells and tissues |
| Q44633804 | Effects of dietary folate intake and folate binding protein-1 (Folbp1) on urinary speciation of sodium arsenate in mice. |
| Q45273892 | Effects of selenium on the structure and function of recombinant human S-adenosyl-L-methionine dependent arsenic (+3 oxidation state) methyltransferase in E. coli |
| Q34558657 | Efficient arsenic metabolism--the AS3MT haplotype is associated with DNA methylation and expression of multiple genes around AS3MT. |
| Q42715293 | Environmental arsenic exposure and DNA methylation of the tumor suppressor gene p16 and the DNA repair gene MLH1: effect of arsenic metabolism and genotype |
| Q21245830 | Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapán and Lagunera regions in Mexico |
| Q36441613 | Expression of AS3MT alters transcriptional profiles in human urothelial cells exposed to arsenite |
| Q28397017 | Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh |
| Q24811655 | Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh |
| Q36350858 | Folic Acid and Creatine as Therapeutic Approaches to Lower Blood Arsenic: A Randomized Controlled Trial. |
| Q36094397 | Folic acid supplementation lowers blood arsenic |
| Q24605527 | From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia |
| Q87606076 | From schizophrenia risk locus to schizophrenia genes |
| Q33964153 | Functional characterization of two variant human GSTO 1-1s (Ala140Asp and Thr217Asn). |
| Q50930904 | Functional evaluation of Asp76, 84, 102 and 150 in human arsenic(III) methyltransferase (hAS3MT) interacting with S-adenosylmethionine. |
| Q35426674 | Genetic polymorphisms in glutathione S-transferase (GST) superfamily and risk of arsenic-induced urothelial carcinoma in residents of southwestern Taiwan. |
| Q46217936 | Genetic variants associated with arsenic metabolism within human arsenic (+3 oxidation state) methyltransferase show wide variation across multiple populations |
| Q37235645 | Genetic variations associated with interindividual sensitivity in the response to arsenic exposure |
| Q35121842 | Genomic evidence reveals the extreme diversity and wide distribution of the arsenic-related genes in Burkholderiales. |
| Q26774259 | Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants |
| Q42463468 | High accumulation of arsenic in the esophagus of mice after exposure to arsenite. |
| Q36089643 | High-throughput screening-compatible assays of As(III) S-adenosylmethionine methyltransferase activity |
| Q34465718 | Human adaptation to arsenic-rich environments |
| Q34483719 | Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies |
| Q40264955 | Identification and catalytic residues of the arsenite methyltransferase from a sulfate-reducing bacterium, Clostridium sp. BXM. |
| Q35844220 | Identification of Small Molecule Inhibitors of Human As(III) S-Adenosylmethionine Methyltransferase (AS3MT) |
| Q28660913 | Identification of the third binding site of arsenic in human arsenic (III) methyltransferase |
| Q33820155 | In vitro assays of inorganic arsenic methylation |
| Q35079230 | Individual variations in inorganic arsenic metabolism associated with AS3MT genetic polymorphisms. |
| Q33569457 | Influence of cobalamin on arsenic metabolism in Bangladesh |
| Q33840667 | Interaction between arsenic exposure from drinking water and genetic susceptibility in carotid intima-media thickness in Bangladesh |
| Q33954260 | Interaction of plasma glutathione redox and folate deficiency on arsenic methylation capacity in Bangladeshi adults |
| Q33823587 | Interspecies differences in metabolism of arsenic by cultured primary hepatocytes |
| Q37091529 | Investigating arsenic susceptibility from a genetic perspective in Drosophila reveals a key role for glutathione synthetase |
| Q35044729 | Involvement of N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) in arsenic biomethylation and its role in arsenic-induced toxicity |
| Q39184989 | Knockout of arsenic (+3 oxidation state) methyltransferase is associated with adverse metabolic phenotype in mice: the role of sex and arsenic exposure |
| Q34026034 | Life and death with arsenic. Arsenic life: an analysis of the recent report "A bacterium that can grow by using arsenic instead of phosphorus". |
| Q38003650 | Linking selenium biogeochemistry to the sulfur-dependent biological detoxification of arsenic |
| Q39643756 | Manipulation of Expression of Arsenic (+3 Oxidation State) Methyltransferase in Cultured Cells |
| Q35574373 | Mathematical model insights into arsenic detoxification |
| Q36628920 | Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase. |
| Q38027433 | Metabolism of arsenic and its toxicological relevance |
| Q24678196 | Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms |
| Q34547184 | Methylarsonous acid transport by aquaglyceroporins. |
| Q41540503 | Methylated Phenylarsenical Metabolites Discovered in Chicken Liver |
| Q34567906 | Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment |
| Q38620066 | Methylated trivalent arsenic-glutathione complexes are more stable than their arsenite analog |
| Q36227529 | Methylation of arsenic by recombinant human wild-type arsenic (+3 oxidation state) methyltransferase and its methionine 287 threonine (M287T) polymorph: Role of glutathione. |
| Q42477840 | NFE2L2 Gene Variants and Arsenic Susceptibility: A Lymphoblastoid Model. |
| Q37620481 | Nephroprotective effect of astaxanthin against trivalent inorganic arsenic-induced renal injury in wistar rats |
| Q40631105 | Novel polymorphisms influencing transcription of the human CHRM2 gene in airway smooth muscle |
| Q88812333 | Nutritional Influences on One-Carbon Metabolism: Effects on Arsenic Methylation and Toxicity |
| Q28382946 | Nutritional manipulation of one-carbon metabolism: effects on arsenic methylation and toxicity |
| Q37725102 | Oxidation state specific analysis of arsenic species in tissues of wild-type and arsenic (+3 oxidation state) methyltransferase-knockout mice |
| Q35035675 | Oxidative stress as a possible mode of action for arsenic carcinogenesis |
| Q42931475 | Pathological, immunological and biochemical markers of subchronic arsenic toxicity in rats |
| Q34444053 | Pathway of human AS3MT arsenic methylation. |
| Q42045107 | Pentavalent methylated arsenicals are substrates of human AQP9. |
| Q78566284 | Pharmacokinetic modeling of arsenite uptake and metabolism in hepatocytes--mechanistic insights and implications for further experiments |
| Q34159791 | Polymorphisms in arsenic(+III oxidation state) methyltransferase (AS3MT) predict gene expression of AS3MT as well as arsenic metabolism |
| Q43707489 | Position-specific isotope analysis of the methyl group carbon in methylcobalamin for the investigation of biomethylation processes |
| Q36977314 | Positive selection of AS3MT to arsenic water in Andean populations |
| Q36557564 | Possible positive selection for an arsenic-protective haplotype in humans |
| Q40011614 | Potentiation of arsenic neurotoxicity by folate deprivation: protective role of S-adenosyl methionine |
| Q35845207 | Purification of arsenic (+3 oxidation state) methyltransferase from rat liver cytosol |
| Q91497136 | Recent population genomic insights into the genetic basis of arsenic tolerance in humans: the difficulties of identifying positively selected loci in strongly bottlenecked populations |
| Q40494874 | Recurrent horizontal transfer of arsenite methyltransferase genes facilitated adaptation of life to arsenic. |
| Q42806745 | Reduction of anti-leishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase, TDR1. |
| Q28385894 | Renal function is associated with indicators of arsenic methylation capacity in Bangladeshi adults |
| Q35017063 | Residues in human arsenic (+3 oxidation state) methyltransferase forming potential hydrogen bond network around S-adenosylmethionine |
| Q36700525 | Rice-arsenate interactions in hydroponics: whole genome transcriptional analysis |
| Q34306534 | S-adenosylmethionine in liver health, injury, and cancer |
| Q50053204 | Serum homocysteine, arsenic methylation, and arsenic-induced skin lesion incidence in Bangladesh: A one-carbon metabolism candidate gene study |
| Q36803731 | Speciation analysis of arsenic in biological matrices by automated hydride generation-cryotrapping-atomic absorption spectrometry with multiple microflame quartz tube atomizer (multiatomizer). |
| Q37007978 | Speciation of arsenic in exfoliated urinary bladder epithelial cells from individuals exposed to arsenic in drinking water |
| Q46974689 | Sulforaphane, an activator of Nrf2, suppresses cellular accumulation of arsenic and its cytotoxicity in primary mouse hepatocytes |
| Q36339038 | The epigenetic effects of a high prenatal folate intake in male mouse fetuses exposed in utero to arsenic |
| Q38978392 | The organoarsenical biocycle and the primordial antibiotic methylarsenite |
| Q24812468 | The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update |
| Q36672637 | Transcriptional Modulation of the ERK1/2 MAPK and NF-κB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer |
| Q33354347 | Transcriptomic changes and signalling pathways induced by arsenic stress in rice roots |
| Q24811470 | Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. |
| Q44509029 | Variability in human metabolism of arsenic |
| Q36579671 | shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells |
Search more.